Skip to main content

Molecularly Targeted Anti-Cancer Therapies

Basic Details
Date Posted
Status
Complete
Medical Product
axitinib
bicalutamide
crizoatinib
dasatinib
erlotinib HCL
everolimus
gefitinib
imatinib mesylate
lapatinib ditosylate
nilotinib HCL
pazopanib HCL
ruxolitinib phosphate
sorafenib tosylate
sunitinib malate
tamoxifen citrate
vandetanib
vemurafenib
vismodegib
Description

These reports look at the use of 18 selected generic drug products relating to molecularly targeted anti-cancer therapies in the Mini-Sentinel Distributed Database (MSDD). These results were generated using the Mini-Sentinel Distributed Query Tool. This query was run against the Dispensing Summary Table and distributed on May 10, 2013 to 17 Data Partners; this report includes information from 17 Data Partners. 

Deliverables (2)
Mini-Sentinel Summary Table Report: Molecularly Targeted Anti-Cancer Therapies Report 1 Mini-Sentinel Summary Table Report: Molecularly Targeted Anti-Cancer Therapies Report 2
Additional Details
FDA Center
CDER
Time Period
2000 - 2012
Analysis Type
Summary Table
Population / Cohort
All individuals
Data Sources
Mini-Sentinel Distributed Database (MSDD)